Bernstein Upgrades CVS Health (CVS) Stock to Outperform from Market Perform

CVS Health Corporation (NYSE:CVS) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 12, Bernstein analyst Lance Wilkes upgraded the company’s stock to “Outperform” from “Market Perform” with a price objective of $94, an increase from the prior target of $91. This upgrade demonstrates CVS Health Corporation (NYSE:CVS)’s attractive exposure to the Medicare Advantage turnaround and expectations of stable earnings in the pharmacy and pharmacy benefit manager businesses after the refo ...